New Adjuvant Chemotherapy of Non Resectable Liver Metastasis of Colorectal Cancer Without Bleeding, Obstruction

• Status: Unknown status
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation of new adjuvant chemotherapy for unresectable liver metastasis of colorectal cancer without bleeding, obstruction, etc.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fudan University
• Collaborators: Ruijin Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang University; Shanghai 6th People's Hospital; Shanghai 9th People's Hospital; Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University; The First Affiliated Hospital with Nanjing Medical University; Zhejiang University

Criteria

Inclusion Criteria:

• age between 18 - 75 years old

• colorectal adenocarcinoma pathologically

• without any chemotherapy or radiotherapy

• unresectable liver metastasis and without other metastasis

• resectable colorectal cancer

• suitable for chemotherapy

• agreed by patients

Exclusion Criteria:

• age below 18 years old or greater than 75 years old

• haven't pathological diagnosis of colorectal adenocarcinoma

• with any chemotherapy or radiotherapy

• resectable liver metastasis or without other metastasis

• unresectable colorectal cancer

• unsuitable for chemotherapy

• not agreed by patients